Lindbrook Capital, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,793
+7.9%
1170.0%0.00%0.0%
Q2 2023$6,298
+35.5%
1170.0%0.00%0.0%
Q1 2023$4,647
-7.6%
117
-6.4%
0.00%0.0%
Q4 2022$5,029
+25.7%
1250.0%0.00%0.0%
Q3 2022$4,0000.0%1250.0%0.00%0.0%
Q2 2022$4,000
+33.3%
125
+13.6%
0.00%
Q1 2022$3,000
-81.2%
110
-45.0%
0.00%
-100.0%
Q2 2019$16,0002000.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 200,000$13,270,00021.02%
Healthcare Value Capital, LLC 50,000$3,318,0005.26%
Consonance Capital Management LP 653,258$43,344,0004.17%
1492 Capital Management LLC 34,500$2,289,0001.87%
JW Asset Management, LLC 29,722$1,972,0001.36%
FRANKLIN STREET ADVISORS INC /NC 29,000$1,924,0000.35%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 55,705$3,696,0000.27%
Ativo Capital Management LLC 15,805$1,049,0000.24%
DIKER MANAGEMENT LLC 9,810$651,0000.23%
CASTLEARK MANAGEMENT LLC 100,615$6,676,0000.20%
View complete list of ANI PHARMACEUTICALS INC shareholders